You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

22 Items

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Updated

Mar 2024

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer

Document Status: Current
ID: GL MOTAC-4
Version: 2

Jan 2022

Consensus Pathology Recommendations for Mesenchymal Tumours of Soft Tissue and Bone

Document Status: Current
Version: 1.0

Mar 2023

Enhancing Clinical Cancer Genetic Service Delivery in Ontario - Recommendations for a New Model of Care

Document Status: Current
Version: 1.0

Dec 2020

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Document Status: Current
Version: 1

Apr 2023

Follow-up Care, Surveillance Protocols and Secondary Prevention Measures for Survivors of Colorectal Cancer

Document Status: Current
ID: GL 26-2
Version: 3

Mar 2021

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Document Status: Current
ID: N/A
Version: N/A

Mar 2019

Guideline for Optimization of Surgical and Pathological Quality Performance for Radical Prostatectomy in Prostate Cancer Management

Document Status: Current
ID: 17-3
Version: 2

Oct 2017

Hereditary Cancer Testing Eligibility Criteria: Version 3

Document Status: Current
Version: 3

Oct 2022

Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants

Document Status: Current
ID: GL-END MOTAC 5

Aug 2017